Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
Clinical trial NCT01271452 · COMPLETED
Trial details
- NCT number
- NCT01271452
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.